Developer docs
API playgroundTry for free, no card

Search company profiles

Reset Health

Full company profile

uuid0008pms

Namestring
Reset Health
Legal namestring
Reset Health Limited
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Reset Health is a London-based digital health company founded in 2019 that designs metabolic care programmes and a proprietary technology platform to treat obesity, Type 2 diabetes, and metabolic syndrome as chronic conditions. The company's core offering is the Reset Technology Platform (RTP), a digital clinical system that connects patients with multidisciplinary teams of doctors, dietitians, nurses, and psychologists, supporting virtual consultations, clinical messaging, behaviour change tools, and long-term outcome monitoring. On top of this platform sits the Roczen programme — a digitally delivered, clinician-led weight management intervention built around time-restricted eating, behavioural coaching, and peer support — and Roczen Plus, which bundles GLP-1/GIP and GLP-1 pharmacotherapy (Wegovy, Mounjaro) with the same clinical wraparound. The platform can be deployed as a white-labelled app or co-branded service, enabling tailored partner integrations.

Short descriptiontext

Reset Health is a London-based digital health company that designs metabolic care programmes and a proprietary technology platform for treating obesity, Type 2 diabetes, and related chronic conditions, serving NHS trusts, employers, pharmaceutical companies, and private healthcare providers through NHS partnerships, white-label deployments, and direct-to-consumer subscriptions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chronic disease management, digital health platform, metabolic health programs, weight management services, obesity care pathways
Industry4 codes
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAIAH
Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALADAD
Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLACAGAG
Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
NAICS code2 codes
  • Diet and Weight Reducing Centers812191
  • All Other Outpatient Care Centers621498
SIC code2 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Digital Health Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1NHS and Health System Contracts
TypeSubscription Recurring
Description

Reset Health partners with NHS trusts, ICBs, and national health systems to deliver structured, scalable obesity care programmes. Revenue is generated through service agreements with public health systems, providing clinical governance, technology infrastructure, and multidisciplinary expertise.

resethealth.clinic
2Employer Health Benefits
TypeSubscription Recurring
Description

Reset Health provides organisations with specialist, clinically led care for obesity and related chronic conditions as part of employee health benefits. Employers pay for access to the platform and clinical services to support workforce wellbeing.

resethealth.clinic
3Pharma & Life Sciences Partnerships
TypeManaged Services
Description

Reset Health supports life sciences partners to deliver clinically governed patient programmes in real-world settings. Services include therapy initiation support, post-market surveillance, side-effect management, pharmacovigilance, and real-world data capture that demonstrates value for pharmaceutical partners.

resethealth.clinic
4Direct-to-Consumer (Roczen Plus)
TypeSubscription Recurring
Description

Individual patients subscribe to the Roczen Plus medication-assisted weight loss programme starting from £195 per month. The subscription includes doctor-prescribed weekly doses of medication, 1-1 guidance from clinical team, monthly check-ins, personalised diet and exercise plans, and app access.

resethealth.clinic
5Private Provider Partnerships
TypeLicensing Royalties
Description

Reset Health extends and strengthens existing services for pharmacy networks, independent providers, and academic partners through its platform, combining clinical governance, technology infrastructure, and multidisciplinary expertise.

resethealth.clinic
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1Roczen Plus medication-assisted programme
ModelSubscriptionBilling cadenceMonthly
Notes

Starts from £195 per month, depending on recommended medication and dosage. Includes: doctor-prescribed weekly doses of medication delivered to door, 1-1 guidance from expert team of doctors, nurses, dietitians and psychologists, monthly check-ins with clinical team, personalised diet and exercise plan, HbA1c blood test, exclusive app access with community support groups, 300+ healthy recipes, clinician-authored blogs, and fitness guides.

resethealth.clinic
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Roczen
Description

Integrated care model for metabolic health delivering weight management programmes, including time-restricted eating protocols and lifestyle interventions alongside GLP-1 medications

resethealth.clinic
+2 more records
Core offering1 text field

Reset Health designs and delivers clinically led, technology-enabled chronic care programmes for obesity, type 2 diabetes, and metabolic syndrome through its proprietary Reset Technology Platform (RTP) and Roczen care model. It combines multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists) with a digital platform, offering B2B partnerships (NHS health systems, employers, pharmaceutical companies, private providers) as well as direct-to-consumer subscription services (Roczen Plus). The platform supports white-label deployment and integrates GLP-1/GIP pharmacotherapy with structured behavioural and dietary interventions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Mean weight loss of 8.6kg (-8.7%) at 12 months across diverse patient population (n=132, p<0.0001)
+7 more records
Product overview1 text field

Reset Health delivers integrated chronic care through a platform-plus-products architecture. The Reset Technology Platform (RTP) serves as the core infrastructure—a proprietary digital clinical system that connects patients with multidisciplinary teams and enables scalable, evidence-based care delivery across health systems, employers, pharma, and private providers. Built on RTP, Roczen is the primary clinical service brand: a doctor-led, digitally delivered weight management programme for obesity and related metabolic conditions, combining time-restricted eating, behavioural coaching, peer support, and whole-food dietary guidance via a mobile app. Roczen Plus extends the programme by integrating GLP-1/GIP and GLP-1 pharmacotherapy (Wegovy, Mounjaro) with the same clinical wraparound care, targeting sustained weight loss and long-term maintenance. RTP supports flexible deployment—as a white-labelled app or co-branded service—to meet partner needs.

Product and service3 records
1Reset Technology Platform (RTP)
CategoryDigital Health Platform
Description

Proprietary cohesive digital clinical system designed to optimise therapeutic care for chronic conditions including obesity and Type 2 diabetes. Connects patients with multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists), enables virtual consultations, clinical messaging, referral processing, and long-term outcome monitoring. Can be deployed as a fully white-labelled app or co-branded service for partners (NHS, employers, pharma, private providers).

2Roczen
CategoryWeight Management Programme
Description

Digital, clinically led weight management programme treating obesity as a chronic condition. Combines time-restricted eating (TRE), behavioural coaching, peer-led support, and whole-food dietary guidance delivered through a mobile app. Led by NHS obesity specialists with multidisciplinary clinical teams. Designed for use with or without pharmacotherapy. NICE-evaluated with time-limited recommendation for early use within the NHS until March 2028.

3Roczen Plus
CategoryMedication-Assisted Weight Management
Description

Medication-assisted weight management programme combining the Roczen clinical programme with GLP-1/GIP or GLP-1 weight-loss medications (Wegovy, Mounjaro). Includes doctor-prescribed weekly medication doses, one-to-one clinician guidance, monthly check-ins, personalised diet and exercise plans, HbA1c blood testing, and app access with community support. Subscription starts from £195 per month.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-20
Description

Clinical partnership to transform specialist obesity services, reducing waiting times from 2 years to 8 days, eliminating out-of-area placements, and moving 1,600+ appointments out of secondary care. Reset Health provides its integrated care platform enabling personalised multidisciplinary care through virtual consultations, clinical messaging, and long-term outcome monitoring.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-20
Description

Joint partnership with ESNEFT to transform specialist obesity services across the region. ICB partners with Reset Health to deliver digitally enabled, locally delivered complex obesity care that is genuinely personalised and accessible.

3Pharmacy2U
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-18
Description

Strategic partnership with UK's largest online pharmacy to deliver end-to-end obesity treatment and care. Combines rapid GLP-1 access through Pharmacy2U with expert clinical wraparound care from Reset Health. Launches Q1 2026.

resethealth.clinic
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

Pan-European strategic long-term collaboration to launch Roczen to Affidea's 14 million patients. Roczen will be rolled out across Affidea markets providing personalised obesity and Type 2 diabetes care combining sustainable lifestyle changes with medical interventions.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

Joint white paper partnership exploring NHS concerns around obesity care and providing a data-driven, digitally-enabled solution through a Community Obesity Management Service. Uses IQVIA's healthcare data expertise with Reset Health's Roczen platform.

Strategic tierStrategicTypeGTM or Marketing Partner
Description

Pharmaceutical partner and GLP-1 manufacturer. Advisory board includes Pinder Sahota, former General Manager of Novo Nordisk UK. Reset Health supports patients using Novo Nordisk obesity medications with clinical wraparound care.

Strategic tierStrategicTypeGTM or Marketing Partner
Description

Pharmaceutical partner and GLP-1/GIP manufacturer (Mounjaro/tirzepatide). Reset Health provides clinical support programmes for patients using Eli Lilly obesity medications.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Pharmaceutical distributor partner providing access to medications and healthcare products across Asian markets where Reset Health operates.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Digital chronic condition management platform spanning diabetes, hypertension and obesity with strong B2B payer and employer focus. Comparable chronic-disease multimorbidity positioning and AI-driven personalised care pathways to Reset Health's RTP.

2Noom
TypeBroad incumbent
Description

Large-scale consumer digital weight-loss platform with growing GLP-1 companion offerings and enterprise health partnerships. Operates across the same end-user weight-loss category as Reset Health but with a much broader consumer brand and DTC focus.

TypeDirect peer
Description

UK digital weight-management programme combining app-based coaching, behaviour change and optional GLP-1 medication pathways, with NHS and employer contracts. Highly comparable to Roczen Plus in its consumer-plus-clinical model.

TypeDirect peer
Description

Digital health platform powering regulated remote patient monitoring and chronic care pathways for health systems and pharma. Directly comparable to Reset Health's RTP in combining a regulated clinical platform with real-world data capture for life-sciences partners.

TypeDirect peer
Description

Digital chronic disease prevention and management platform offering coach-led programmes for obesity, diabetes and cardiovascular disease across European health systems. Directly competes with Roczen for NHS-tier-3 weight management and DPP commissioning.

TypeDirect peer
Description

Europe-based digital behaviour-change programme for obesity, type 2 diabetes and related metabolic conditions delivered via app and coach support. Closely mirrors Reset's Roczen programme in combining multidisciplinary coaching with GLP-1-era wraparound care.

7CureApp
TypeEmerging player
Description

Regulated digital therapeutic company developing prescription DTx for conditions including obesity and metabolic disease. Comparable in pursuing regulatory-grade (NICE/MHRA-style) digital therapeutic designations and clinical governance around chronic conditions.

TypeBroad incumbent
Description

Incumbent weight-management brand now offering a clinical / GLP-1 pathway (WW Clinic) and employer programmes. Comparable consumer-plus-clinical model and employer GTM motion versus Reset's Roczen Plus and employer benefits offering.

9Babylon Health
TypeBroad incumbent
Description

UK-headquartered virtual care platform providing telehealth, chronic care and population health tools to NHS and global partners. Comparable to Reset Health's NHS-facing virtual care model, though operating at a broader primary-care level rather than obesity-specialised.

10Vitality Health
TypeRegional player
Description

UK health and life insurer with member wellness and chronic-condition management programmes, including weight management. Comparable employer/payer channel for chronic metabolic care, though primarily insurer-led rather than a standalone digital health platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles25 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reset Health

Digital Health Servicesresethealth.clinic

Reset Health is a London-based digital health company that designs metabolic care programmes and a proprietary technology platform for treating obesity, Type 2 diabetes, and related chronic conditions, serving NHS trusts, employers, pharmaceutical companies, and private healthcare providers through NHS partnerships, white-label deployments, and direct-to-consumer subscriptions.

What Reset Health does

Reset Health is a London-based digital health company founded in 2019 that designs metabolic care programmes and a proprietary technology platform to treat obesity, Type 2 diabetes, and metabolic syndrome as chronic conditions. The company's core offering is the Reset Technology Platform (RTP), a digital clinical system that connects patients with multidisciplinary teams of doctors, dietitians, nurses, and psychologists, supporting virtual consultations, clinical messaging, behaviour change tools, and long-term outcome monitoring. On top of this platform sits the Roczen programme — a digitally delivered, clinician-led weight management intervention built around time-restricted eating, behavioural coaching, and peer support — and Roczen Plus, which bundles GLP-1/GIP and GLP-1 pharmacotherapy (Wegovy, Mounjaro) with the same clinical wraparound. The platform can be deployed as a white-labelled app or co-branded service, enabling tailored partner integrations.

Reset Health firmographics

Firmographics
Name
Reset Health
Legal name
Reset Health Limited
Website
https://resethealth.clinic
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Reset Health is a London-based digital health company that designs metabolic care programmes and a proprietary technology platform for treating obesity, Type 2 diabetes, and related chronic conditions, serving NHS trusts, employers, pharmaceutical companies, and private healthcare providers through NHS partnerships, white-label deployments, and direct-to-consumer subscriptions.
Ownership category
akta.pro rank

Reset Health industry classification

Industry
Product category
Digital Health Services
NAICS
Diet and Weight Reducing Centers (812191), All Other Outpatient Care Centers (621498)
SIC
Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAIAH
Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALADAD
Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLACAGAG
Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

Keywords

  • Chronic disease management
  • Digital health platform
  • Metabolic health programs
  • Weight management services
  • Obesity care pathways

Where Reset Health is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Reset Health business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. NHS and Health System Contracts: Reset Health partners with NHS trusts, ICBs, and national health systems to deliver structured, scalable obesity care programmes. Revenue is generated through service agreements with public health systems, providing clinical governance, technology infrastructure, and multidisciplinary expertise.
  2. Employer Health Benefits: Reset Health provides organisations with specialist, clinically led care for obesity and related chronic conditions as part of employee health benefits. Employers pay for access to the platform and clinical services to support workforce wellbeing.
  3. Pharma & Life Sciences Partnerships: Reset Health supports life sciences partners to deliver clinically governed patient programmes in real-world settings. Services include therapy initiation support, post-market surveillance, side-effect management, pharmacovigilance, and real-world data capture that demonstrates value for pharmaceutical partners.
  4. Direct-to-Consumer (Roczen Plus): Individual patients subscribe to the Roczen Plus medication-assisted weight loss programme starting from £195 per month. The subscription includes doctor-prescribed weekly doses of medication, 1-1 guidance from clinical team, monthly check-ins, personalised diet and exercise plans, and app access.
  5. Private Provider Partnerships: Reset Health extends and strengthens existing services for pharmacy networks, independent providers, and academic partners through its platform, combining clinical governance, technology infrastructure, and multidisciplinary expertise.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyRoczen Plus medication-assisted programme

Go-to-market motion1 record

Distribution channels8 records

Marketing channels8 records

Reset Health product offering

Product offering

Core offering

Reset Health designs and delivers clinically led, technology-enabled chronic care programmes for obesity, type 2 diabetes, and metabolic syndrome through its proprietary Reset Technology Platform (RTP) and Roczen care model. It combines multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists) with a digital platform, offering B2B partnerships (NHS health systems, employers, pharmaceutical companies, private providers) as well as direct-to-consumer subscription services (Roczen Plus). The platform supports white-label deployment and integrates GLP-1/GIP pharmacotherapy with structured behavioural and dietary interventions.

Product overview

Reset Health delivers integrated chronic care through a platform-plus-products architecture. The Reset Technology Platform (RTP) serves as the core infrastructure—a proprietary digital clinical system that connects patients with multidisciplinary teams and enables scalable, evidence-based care delivery across health systems, employers, pharma, and private providers. Built on RTP, Roczen is the primary clinical service brand: a doctor-led, digitally delivered weight management programme for obesity and related metabolic conditions, combining time-restricted eating, behavioural coaching, peer support, and whole-food dietary guidance via a mobile app. Roczen Plus extends the programme by integrating GLP-1/GIP and GLP-1 pharmacotherapy (Wegovy, Mounjaro) with the same clinical wraparound care, targeting sustained weight loss and long-term maintenance. RTP supports flexible deployment—as a white-labelled app or co-branded service—to meet partner needs.

Differentiator

Problem solved

Functional benefit

Brands

  • Roczen: Integrated care model for metabolic health delivering weight management programmes, including time-restricted eating protocols and lifestyle interventions alongside GLP-1 medications
  • Roczen Plus
  • Reset Technology Platform (RTP)

Products and services

  • Reset Technology Platform (RTP) Proprietary cohesive digital clinical system designed to optimise therapeutic care for chronic conditions including obesity and Type 2 diabetes. Connects patients with multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists), enables virtual consultations, clinical messaging, referral processing, and long-term outcome monitoring. Can be deployed as a fully white-labelled app or co-branded service for partners (NHS, employers, pharma, private providers).
  • Roczen Digital, clinically led weight management programme treating obesity as a chronic condition. Combines time-restricted eating (TRE), behavioural coaching, peer-led support, and whole-food dietary guidance delivered through a mobile app. Led by NHS obesity specialists with multidisciplinary clinical teams. Designed for use with or without pharmacotherapy. NICE-evaluated with time-limited recommendation for early use within the NHS until March 2028.
  • Roczen Plus Medication-assisted weight management programme combining the Roczen clinical programme with GLP-1/GIP or GLP-1 weight-loss medications (Wegovy, Mounjaro). Includes doctor-prescribed weekly medication doses, one-to-one clinician guidance, monthly check-ins, personalised diet and exercise plans, HbA1c blood testing, and app access with community support. Subscription starts from £195 per month.

Quantifiable outcome

  • Mean weight loss of 8.6kg (-8.7%) at 12 months across diverse patient population (n=132, p<0.0001)
  • +7 more outcomes

Companies that use Reset Health

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles5 records

Reset Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Reset Health partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, strategic and minor.

  • East Suffolk and North Essex NHS Foundation Trust (ESNEFT)coreStrategic or Co-development Partner · 20 March 2026Clinical partnership to transform specialist obesity services, reducing waiting times from 2 years to 8 days, eliminating out-of-area placements, and moving 1,600+ appointments out of secondary care. Reset Health provides its integrated care platform enabling personalised multidisciplinary care through virtual consultations, clinical messaging, and long-term outcome monitoring.
  • Suffolk and North East Essex Integrated Care Board (SNEE ICB)coreStrategic or Co-development Partner · 20 March 2026Joint partnership with ESNEFT to transform specialist obesity services across the region. ICB partners with Reset Health to deliver digitally enabled, locally delivered complex obesity care that is genuinely personalised and accessible.
  • Pharmacy2UcoreStrategic or Co-development Partner · 18 February 2026Strategic partnership with UK's largest online pharmacy to deliver end-to-end obesity treatment and care. Combines rapid GLP-1 access through Pharmacy2U with expert clinical wraparound care from Reset Health. Launches Q1 2026.
  • AffideacoreStrategic or Co-development Partner · 10 February 2026Pan-European strategic long-term collaboration to launch Roczen to Affidea's 14 million patients. Roczen will be rolled out across Affidea markets providing personalised obesity and Type 2 diabetes care combining sustainable lifestyle changes with medical interventions.
  • IQVIAstrategicStrategic or Co-development Partner · 10 February 2026Joint white paper partnership exploring NHS concerns around obesity care and providing a data-driven, digitally-enabled solution through a Community Obesity Management Service. Uses IQVIA's healthcare data expertise with Reset Health's Roczen platform.
  • Novo NordiskstrategicGTM or Marketing PartnerPharmaceutical partner and GLP-1 manufacturer. Advisory board includes Pinder Sahota, former General Manager of Novo Nordisk UK. Reset Health supports patients using Novo Nordisk obesity medications with clinical wraparound care.
  • Eli LillystrategicGTM or Marketing PartnerPharmaceutical partner and GLP-1/GIP manufacturer (Mounjaro/tirzepatide). Reset Health provides clinical support programmes for patients using Eli Lilly obesity medications.
  • Zuellig PharmaminorGTM or Marketing PartnerPharmaceutical distributor partner providing access to medications and healthcare products across Asian markets where Reset Health operates.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Reset Health competitors and assessment

Company assessment

Emerging players

  • DarioHealth: Digital chronic condition management platform spanning diabetes, hypertension and obesity with strong B2B payer and employer focus. Comparable chronic-disease multimorbidity positioning and AI-driven personalised care pathways to Reset Health's RTP.
  • CureApp: Regulated digital therapeutic company developing prescription DTx for conditions including obesity and metabolic disease. Comparable in pursuing regulatory-grade (NICE/MHRA-style) digital therapeutic designations and clinical governance around chronic conditions.

Broad incumbents

  • Noom: Large-scale consumer digital weight-loss platform with growing GLP-1 companion offerings and enterprise health partnerships. Operates across the same end-user weight-loss category as Reset Health but with a much broader consumer brand and DTC focus.
  • WeightWatchers (WW International): Incumbent weight-management brand now offering a clinical / GLP-1 pathway (WW Clinic) and employer programmes. Comparable consumer-plus-clinical model and employer GTM motion versus Reset's Roczen Plus and employer benefits offering.
  • Babylon Health: UK-headquartered virtual care platform providing telehealth, chronic care and population health tools to NHS and global partners. Comparable to Reset Health's NHS-facing virtual care model, though operating at a broader primary-care level rather than obesity-specialised.

Direct peers

  • Second Nature: UK digital weight-management programme combining app-based coaching, behaviour change and optional GLP-1 medication pathways, with NHS and employer contracts. Highly comparable to Roczen Plus in its consumer-plus-clinical model.
  • Huma Therapeutics: Digital health platform powering regulated remote patient monitoring and chronic care pathways for health systems and pharma. Directly comparable to Reset Health's RTP in combining a regulated clinical platform with real-world data capture for life-sciences partners.
  • Liva Healthcare: Digital chronic disease prevention and management platform offering coach-led programmes for obesity, diabetes and cardiovascular disease across European health systems. Directly competes with Roczen for NHS-tier-3 weight management and DPP commissioning.
  • Oviva: Europe-based digital behaviour-change programme for obesity, type 2 diabetes and related metabolic conditions delivered via app and coach support. Closely mirrors Reset's Roczen programme in combining multidisciplinary coaching with GLP-1-era wraparound care.

Regional players

  • Vitality Health: UK health and life insurer with member wellness and chronic-condition management programmes, including weight management. Comparable employer/payer channel for chronic metabolic care, though primarily insurer-led rather than a standalone digital health platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Reset Health social profiles

Digital presence

Reset Health compliance and trust

Trust signal

Compliance3 records

Reset Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reset Health leadership team

Management profile

Number of profiles

Profiles25 records

Reset Health subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Reset Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reset Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reset Health

What does Reset Health do?

Reset Health designs and delivers clinically led, technology-enabled chronic care programmes for obesity, type 2 diabetes, and metabolic syndrome through its proprietary Reset Technology Platform (RTP) and Roczen care model. It combines multidisciplinary clinical teams (doctors, dietitians, nurses, psychologists) with a digital platform, offering B2B partnerships (NHS health systems, employers, pharmaceutical companies, private providers) as well as direct-to-consumer subscription services (Roczen Plus). The platform supports white-label deployment and integrates GLP-1/GIP pharmacotherapy with structured behavioural and dietary interventions.

Is Reset Health a public or private company?

Reset Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Reset Health founded?

Reset Health was founded in 2019. It employs 51 to 100 people.

Where is Reset Health based?

Reset Health is headquartered in London, United Kingdom, in the Europe region.

How does Reset Health make money?

Five revenue lines are on record. NHS and Health System Contracts are the primary driver. The others are employer Health Benefits, pharma & Life Sciences Partnerships, direct-to-Consumer (Roczen Plus) and private Provider Partnerships.

Who are Reset Health's main competitors?

Emerging players on record are DarioHealth and CureApp. Broad incumbents are Noom, WeightWatchers (WW International) and Babylon Health. Direct peers are Second Nature, Huma Therapeutics, Liva Healthcare and Oviva. Vitality Health is listed as a regional player.

Does Reset Health have an API?

No public API is recorded for Reset Health.

What industry is Reset Health in?

Reset Health's product category is Digital Health Services. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLALAIAH, Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing. Its NAICS code is 812191 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical Device NetworkAverly Health launches in UK to advance cardiometabolic careAverly Health launched in the UK, uniting fragmented NHS cardiometabolic care for obesity and type 2 diabetes. The service, backed by Reset Health and Pharmacy2U, supports over two million patients monthly and aims to provide coordinated care from assessment to long-term outcomes.GlobeNewswireReset Health Further Strengthens Advisory Board With Appointment of Pinder SahotaReset Health appointed Pinder Sahota to its Advisory Board, following the recent addition of Professor Sir Jonathan Van-Tam. Sahota previously led GLP-1 development at Novo Nordisk UK and brings over 20 years of life sciences leadership. The appointments support Reset Health's expansion of its integrated care model for obesity and chronic conditions.PR NewswireAffidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its networkAffidea announced a long-term partnership with Reset Health to implement the Roczen digital care platform for obesity and type 2 diabetes management across its pan-European network. The platform combines lifestyle interventions with access to GLP-1 medications and continuous health tracking. The rollout aims to address growing obesity rates, with WHO projections of a 10-15% rise in European obesity by 2030.PR NewswireAffidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its networkAffidea Group announced a long-term partnership with Reset Health to implement the Roczen digital care platform for obesity and type 2 diabetes management across its pan-European network. The platform combines lifestyle interventions with GLP-1 medications and continuous health tracking. The rollout aims to address rising obesity rates, with WHO projections of a 10-15% increase in Europe by 2030.